Chemoinformatic identification of novel inhibitors against Mycobacterium tuberculosis L-aspartate α-decarboxylase.
L-aspartate α-decarboxylase (ADC) belongs to a class of pyruvoyl dependent enzymes and catalyzes the conversion of aspartate to β-alanine in the pantothenate pathway, which is critical for the growth of several micro-organisms, including Mycobacterium tuberculosis (Mtb). Its presence only in micro-o...
Guardado en:
Autores principales: | Reetu Sharma, Roopa Kothapalli, Antonius M J Van Dongen, Kunchithapadam Swaminathan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd245b0e21e44ea9962ebf00920f2769 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Validation of drug-like inhibitors against Mycobacterium tuberculosis L-aspartate α-decarboxylase using nuclear magnetic resonance (1H NMR).
por: Reetu Sharma, et al.
Publicado: (2012) -
Pyrazinamide triggers degradation of its target aspartate decarboxylase
por: Pooja Gopal, et al.
Publicado: (2020) -
Aspartate aminotransferase Rv3722c governs aspartate-dependent nitrogen metabolism in Mycobacterium tuberculosis
por: Robert S. Jansen, et al.
Publicado: (2020) -
Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection
por: Erik J. Hasenoehrl, et al.
Publicado: (2019) -
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
por: Anouke van Rumund, et al.
Publicado: (2021)